DK114644B - Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner. - Google Patents

Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.

Info

Publication number
DK114644B
DK114644B DK98367AA DK98367A DK114644B DK 114644 B DK114644 B DK 114644B DK 98367A A DK98367A A DK 98367AA DK 98367 A DK98367 A DK 98367A DK 114644 B DK114644 B DK 114644B
Authority
DK
Denmark
Prior art keywords
antigenic
preparation
influenza virus
subunit vaccines
virus subunit
Prior art date
Application number
DK98367AA
Other languages
English (en)
Inventor
R Webster
W Laver
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Publication of DK114644B publication Critical patent/DK114644B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98367AA 1966-02-24 1967-02-23 Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner. DK114644B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2078/66A AU405949B1 (en) 1966-02-24 1966-02-24 Influenza virus sub-unit vaccine
AU396166 1966-04-07

Publications (1)

Publication Number Publication Date
DK114644B true DK114644B (da) 1969-07-21

Family

ID=25609454

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98367AA DK114644B (da) 1966-02-24 1967-02-23 Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.

Country Status (5)

Country Link
AU (1) AU405949B1 (da)
DK (1) DK114644B (da)
FR (1) FR1587329A (da)
GB (1) GB1140316A (da)
NL (1) NL6702701A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US7270990B2 (en) 2003-06-20 2007-09-18 Microbix Biosystems, Inc. Virus production
AU2009227674C1 (en) 2008-03-18 2015-01-29 Seqirus UK Limited Improvements in preparation of influenza virus vaccine antigens

Also Published As

Publication number Publication date
DE1617288A1 (de) 1971-02-18
FR1587329A (da) 1970-03-20
AU405949B1 (en) 1970-09-18
GB1140316A (en) 1969-01-15
NL6702701A (da) 1967-08-25

Similar Documents

Publication Publication Date Title
DK114289B (da) Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.
DK117316B (da) Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus.
DK127415B (da) Fremgangsmåde til fremstilling af α-benzyl-β,β-dialkoxypropionitriler.
DK121454B (da) Fremgangsmåde til fremstilling af en hjælpestofholdig vaccine.
DK119111B (da) Fremgangsmåde til fremstilling af oxazolidinonderivater.
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK108985C (da) Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.
DK114644B (da) Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.
DK119724B (da) Fremgangsmåde til fremstilling af en antigenfri vaccine.
DK110208C (da) Fremgangsmåde til fremstilling af influenza-vacciner.
DK104193C (da) Fremgangsmåde til stabilisering af labile, antigene virusmaterialer.
DK120752B (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK115888B (da) Fremgangsmåde til fremstilling af vandopløselige, eventuelt modificerede alkydharpikser.
DK119939B (da) Fremgangsmåde til fremstilling af tetanus-vaccine.
DK116752B (da) Fremgangsmåde til fremstilling af et injicerbart influenzavaccinepræparat.
DK113866B (da) Fremgangsmåde til fremstilling af somatiske antigenvacciner.
DK132447B (da) Fremgangsmåde til fremstilling af kalvediarrevirusvaccine.
DK106328C (da) Fremgangsmåde til fremstilling af 17α-alkoxy-16-methylen-3,20-diketopregnanderivater.
DK124340B (da) Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine.
DK116736B (da) Fremgangsmåde til fremstilling af 5-chlor-2,3-pyridindiol.
DK104013C (da) Fremgangsmåde til fremstilling af en somatisk antigenvaccine.
DK128279B (da) Fremgangsmåde til fremstilling af α,ω-alkylendiaminer.
DK130307B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17β-hydroxy-17α-ethynylgona-4,9-diener.
DK124205B (da) Analogifremgangsmåde til fremstilling af 6-klor-4-metylamino-1H-2,3-benzoxazin.
DK118765B (da) Fremgangsmåde til fremstilling af β-isomere oximcarbamatderivater.